Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
BulgariaStudy on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis
ItalyStudy on Capsaicin for Treating Post-Surgical Neuropathic Pain in Patients
FranceStudy on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer's Disease
CzechiaStudy on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy
AustriaStudy on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine
CzechiaStudy on the Effects of Semaglutide in Patients with Early Alzheimer's Disease
AustriaStudy on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis
CzechiaStudy on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
BelgiumStudy on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer's Disease
FinlandStudy on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients
BulgariaStudy on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease
BulgariaThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
